TCE2 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Celldex Therapeutics Inc

Watchlist Manager

Watchlist

Price: 28.3 EUR -3.18%

Market Cap: €1.3B

C	Celldex Therapeutics Inc SWB:TCE2	US
C	China Coal Energy Co Ltd F:CVV	CN
A	Air Products and Chemicals Inc F:AP3	US
	Essential Properties Realty Trust Inc F:2OU	US
O	One Enterprise PCL SET:ONEE	TH
T	TransAlta Corp XMUN:TZ1	CA
	China Citic Bank Corp Ltd F:D7C	CN
	Vornado Realty Trust NYSE:VNO	US
M	Mitsubishi Chemical Holdings Corp OTC:MTLHY	JP
K	Kawasaki Heavy Industries Ltd SWB:KHE	JP
P	Power Corporation of Canada OTC:PWCDF	CA
	Symbotic Inc NASDAQ:SYM	US
	Adial Pharmaceuticals Inc NASDAQ:ADIL	US
T	Trip.com Group Ltd NASDAQ:TCOM	CN
C	COSCO SHIPPING Development Co Ltd XMUN:EZ5	CN
	Invisio AB LSE:0R86	SE
N	NRG Energy Inc XMUN:NRA	US

Profitability Summary

Celldex Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-35.688%

Negative 3Y Average Operating Margin

-7.449%

Declining Operating Margin

-3.720% > -35.688%

Negative Net Margin

-32.754%

Negative 3Y Average Net Margin

-6.693%

Declining Net Margin

-3.470% > -32.754%

Negative Free Cash Flow Margin

-26.126%

Negative 3Y Average Free Cash Flow Margin

-5.597%

Declining Free Cash Flow Margin

-3.506% > -26.126%

Negative ROE

-49%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-396%

Declining ROIC

-267% > -551%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.